Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The 343 patent expires much later (in 2031) than the 122 patent (in 2026)
Established Efficacy: Extensive research supports the effectiveness and safety of injectable semaglutide for weight management
A new 4 mg maintenance-dose arm is under evaluation and may define the post-titration strategy once primary weight loss is achieved
In fact, members in the top 25% of Noom app usage were: 100% more likely to renew following their trial month 44% more likely to renew again after that
Conversely, differences in glycemic control were significant only for those who were diagnosed with both obesity and T2DM, but not for those with either obesity alone or T2DM alone
(Basel) 13, 252
